Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic G Barr

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Pediatric Blood & Cancer|May 20, 2025
Clinicopathologic Features, Management, and Outcomes Of Pediatric CRTC1::TRIM11 and MED15::ATF1 Tumors With Spitzoid Morphology: A Case SeriesMichael R Sargen, Madeline H Fitzhugh, Jennifer S Ko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2022
The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma ModelsKatie E Hebron, Xiaolin Wan, Jacob S Roth, et al.
Science Signaling|November 22, 2018
The HDAC3-SMARCA4-miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcomaNarendra Bharathy, Noah E Berlow, Eric Wang, et al.
Cancers|March 28, 2026
Biological Advances and Current Challenges for Pediatric RhabdomyosarcomaKatie E Hebron, Patience Odeniyide, Yun Wei, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Pediatric Blood & Cancer|May 20, 2025
Clinicopathologic Features, Management, and Outcomes Of Pediatric CRTC1::TRIM11 and MED15::ATF1 Tumors With Spitzoid Morphology: A Case SeriesMichael R Sargen, Madeline H Fitzhugh, Jennifer S Ko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2022
The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma ModelsKatie E Hebron, Xiaolin Wan, Jacob S Roth, et al.
Science Signaling|November 22, 2018
The HDAC3-SMARCA4-miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcomaNarendra Bharathy, Noah E Berlow, Eric Wang, et al.
Cancers|March 28, 2026
Biological Advances and Current Challenges for Pediatric RhabdomyosarcomaKatie E Hebron, Patience Odeniyide, Yun Wei, et al.
Pageof 10